Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vir Biotechnology Inc (NQ: VIR ) 8.660 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Vir Biotechnology Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Why Vir Biotechnology Stock Is Sliding Today November 05, 2021 Efficacy results for oral antivirals from Pfizer and Merck are weighing heavily on Vir today. Via The Motley Fool Exposures COVID-19 The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 Unusual Options Activity Insight: Vir Biotechnology July 30, 2021 Shares of Vir Biotechnology (NASDAQ:VIR) saw some unusual ... Via Benzinga The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal July 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... Via Benzinga Exposures COVID-19 The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga GlaxoSmithKline Drops Research On Otilimab In COVID-19 October 27, 2021 GlaxoSmithKline Plc (NYSE: GSK), in its Q3 earnings release, revealed that it is stopping the development of otilimab in COVID-19 in patients who are at least 70 years... Via Benzinga Exposures COVID-19 Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021 October 25, 2021 Upgrades According to Wedbush, the prior rating for Regions Financial Corp (NYSE: Via Benzinga 10 Biggest Price Target Changes For Monday October 25, 2021 Wells Fargo boosted Bank of America Corporation (NYSE:B... Via Benzinga GlaxoSmithKline: My Top Value Stock For The Week October 23, 2021 GSK, one of the biggest pharmaceuticals companies in the world, is seeing a lot of success with new drugs and plenty more in the pipeline. Better yet for would-be investors, the stock is still very... Via Talk Markets Moderna Slapped With Sell Rating Despite CDC Authorization For Covid Boosters October 22, 2021 The CDC authorized boosters from J&J, Moderna and a mix-and-match approach. Via Investor's Business Daily The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies October 15, 2021 Companies working on sorely needed Covid treatments are innovating to keep up. Via Investor's Business Daily AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial October 11, 2021 AstraZeneca Plc (NASDAQ: AZN) released top-line data from the TACKLE Phase 3 trial in which its experimental COVID-19 drug has helped cut the risk of severe disease... Via Benzinga Exposures COVID-19 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 06, 2021 Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market session. The company's market cap stands at $136.9... Via Benzinga Tesla and Merck Give Investors Some Hope October 04, 2021 Friday’s rally appears to have lost its momentum over the weekend because stock futures are trading lower before Monday’s open. China’s troubled real estate... Via Benzinga 54 Biggest Movers From Friday October 04, 2021 Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc.... Via Benzinga Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher October 01, 2021 Toward the end of trading Friday, the Dow traded up 1.49% to 34,346.53 while the NASDAQ rose 0.75% to 14,556.92. The S&P also rose, gaining 1.18% to 4,358.52. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Friday's Intraday Session October 01, 2021 Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume... Via Benzinga Merck Stock Surges Into Buy Zone As Covid Pill Reduces Risk Of Death, Hospitalization October 01, 2021 Merck said its Covid pill, molnupiravir, cut the risk of death and hospitalization by half. Via Investor's Business Daily Topics Stocks Exposures US Equities Glaxo - Vir Biotech's COVID Treatment Approved In Japan September 27, 2021 Japan's health ministry expert committee has approved GlaxoSmithKline Plc (NYSE: GSK) - Vir Biotechnology Inc's (NASDAQ: VIR) sotrovimab, a COVID-19... Via Benzinga The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug September 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... Via Benzinga Exposures COVID-19 Why Vir Biotechnology Stock Is Sinking This Week September 24, 2021 Shares fell after an analyst's downgrade. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021 September 22, 2021 Upgrades Argus Research upgraded the previous rating for Simon Property Group Inc (NYSE: Via Benzinga Vir Biotechnology Earnings Perspective: Return On Capital Employed September 06, 2021 According to Benzinga Pro, during Q2, Vir Biotechnology (NASDAQ:VIR) earned $61.02 million, a 138.46% increase from the preceding quarter. Vir Biotechnology also posted a total of... Via Benzinga Now May Be the Big Moment for These 2 COVID Stocks September 02, 2021 Their products are seeing a surge in demand. Via The Motley Fool Exposures COVID-19 9 Health Care Stocks With Unusual Options Alerts In Today's Session August 23, 2021 This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... Via Benzinga Vir Biotech-GSK's COVID-19 Treatment Wins Provisional Approval In Australia August 23, 2021 The Australian Therapeutic Goods Administration has granted provisional marketing authorization for Vir Biotechnology Inc's (NASDAQ: VIR) for sotrovimab,... Via Benzinga Exposures COVID-19 3 Vaccine Stocks for the Next Decade August 09, 2021 Because of COVID-19, vaccine stocks have been fantastic investments over the last couple of years. What should investors expect over the next 10 years? Via The Motley Fool Exposures COVID-19 European Commission To Procure 220K Doses Of Glaxo-Vir Biotech's COVID-19 Antibody July 28, 2021 GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of... Via Benzinga Exposures COVID-19 Vir Biotechnology Starts Dosing In Mid-Stage Hepatitis B Trial With Combination Therapy July 15, 2021 Vir Biotechnology Inc (NASDAQ: VIR) has dosed the first patient in the Phase 2 MARCH trial evaluating VIR-2218 in combination with VIR-3434 to treat patients with... Via Benzinga Earnings Scheduled For August 5, 2021 August 05, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.